Security Snapshot

COMPUGEN LTD - Ordinary Shares, par value NIS 0.01 (CGEN) Institutional Ownership

CUSIP: M25722105

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

76

Shares (Excl. Options)

14,189,039

Price

$2.13

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Type / Class
Equity / Ordinary Shares, par value NIS 0.01
Symbol
CGEN on Nasdaq
Shares outstanding
89,326,990
Price per share
$2.83
All holders as of 31 Mar 2026
Q1 2026
Total 13F shares
14,189,039
Total reported value
$30,222,405
% of total 13F portfolios
0%
Share change
+1,595,068
Value change
+$3,573,815
Number of holders
76
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Key facts

  • CGEN - COMPUGEN LTD - Ordinary Shares, par value NIS 0.01 is tracked under CUSIP M25722105.
  • 76 institutions reported positions in Q1 2026.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 69 to 76 between Q4 2025 and Q1 2026.
  • Reported value moved from $19,268,351 to $30,222,405.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 76 institutions filings for Q1 2026.

Open SEC Evidence

Security key

M25722105

Latest holder period

Q1 2026

13F holders

76

13D/G owners

1

CIK / CUSIP context first

Open Q1 2026 holders CGEN full holder history COMPUGEN LTD SEC filings COMPUGEN LTD company facts COMPUGEN LTD insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
1
Security
CGEN
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BRISTOL MYERS SQUIBB CO 2.1% $2,723,401 1,840,136 BRISTOL MYERS SQUIBB CO 31 Dec 2024

As of 31 Mar 2026, 76 institutional investors reported holding 14,189,039 shares of COMPUGEN LTD - Ordinary Shares, par value NIS 0.01 (CGEN). This represents 16% of the company’s total 89,326,990 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
15%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
SILVERARC CAPITAL MANAGEMENT, LLC 3.7% 3,315,845 -4.7% 0.83% $7,062,750
RENAISSANCE TECHNOLOGIES LLC 1.8% 1,632,988 +12% 0.01% $3,478,264
MORGAN STANLEY 1.2% 1,053,229 +4.3% 0% $2,243,377
ARK Investment Management LLC 1.2% 1,049,873 0.02% $2,236,229
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. 1.1% 1,020,000 0% 0% $2,173,000
Taylor Frigon Capital Management LLC 0.95% 848,043 -2.4% 1% $1,806,332
NORTHERN TRUST CORP 0.73% 650,868 -1.2% 0% $1,386,349
TWO SIGMA INVESTMENTS, LP 0.58% 521,587 +72% 0% $1,110,980
STATE STREET CORP 0.46% 415,366 +5.5% 0% $884,730
Yelin Lapidot Holdings Management Ltd. 0.36% 318,852 0% 0.14% $679,155
UBS Group AG 0.34% 306,708 -12% 0% $653,288
DAFNA Capital Management LLC 0.29% 257,783 -5.4% 0.12% $549,078
MARSHALL WACE, LLP 0.27% 244,480 +130% 0% $520,742
MILLENNIUM MANAGEMENT LLC 0.19% 168,927 0% $359,815
WINTON GROUP Ltd 0.18% 156,496 +184% 0.01% $333,336
ROTHSCHILD INVESTMENT LLC 0.16% 140,600 -2.1% 0.02% $299,478
Arax Advisory Partners 0.15% 131,800 0.01% $280,734
CITADEL ADVISORS LLC 0.13% 112,393 -28% 0% $239,398
Cresset Asset Management, LLC 0.12% 111,079 0% $236,598
OSAIC HOLDINGS, INC. 0.12% 109,575 +239% 0% $233,392
RAYMOND JAMES FINANCIAL INC 0.12% 104,889 +0.99% 0% $223,413
Stonepine Capital Management, LLC 0.12% 104,300 -66% 0.2% $222,159
MATRIX ASSET ADVISORS INC/NY 0.11% 93,833 0% 0.02% $199,864
Kingsview Wealth Management, LLC 0.09% 83,179 0% 0% $177,171
EAGLE ROCK INVESTMENT COMPANY, LLC 0.08% 71,212 0% 0.02% $151,682

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
49
Latest
Q1 2026
Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 14,189,039 $30,222,405 +$3,573,815 $2.13 76
2025 Q4 12,593,471 $19,268,351 -$1,280,211 $1.53 69
2025 Q3 12,448,286 $18,304,014 -$4,183,367 $1.47 67
2025 Q2 15,139,685 $26,790,623 +$183,382 $1.78 68
2025 Q1 15,090,164 $22,053,607 +$4,245,948 $1.46 71
2024 Q4 12,186,219 $18,646,397 -$28,651 $1.53 68
2024 Q3 11,987,352 $21,696,784 -$567,864 $1.81 64
2024 Q2 12,305,636 $20,720,522 -$1,505,161 $1.68 65
2024 Q1 12,748,693 $32,862,738 +$5,173,490 $2.58 71
2023 Q4 10,826,281 $21,446,061 -$868,253 $1.98 71
2023 Q3 12,534,496 $11,648,799 +$912,972 $0.93 61
2023 Q2 11,454,619 $13,055,912 +$792,401 $1.14 63
2023 Q1 10,938,583 $7,680,803 -$3,735,798 $0.70 64
2022 Q4 16,116,742 $11,522,279 -$3,810,001 $0.72 66
2022 Q3 21,939,171 $14,470,393 -$27,601,323 $0.66 71
2022 Q2 38,292,142 $70,071,925 -$7,799,772 $1.85 81
2022 Q1 41,974,425 $135,261,109 +$24,332,823 $3.22 103
2021 Q4 34,045,006 $147,109,241 -$8,267,484 $4.30 110
2021 Q3 35,282,290 $210,636,141 -$11,592,998 $5.97 103
2021 Q2 36,945,470 $305,730,622 -$26,358,920 $8.28 105
2021 Q1 40,064,043 $344,003,423 +$10,868,134 $8.59 105
2020 Q4 38,405,443 $465,291,847 -$89,128,926 $12.11 99
2020 Q3 43,347,749 $704,457,313 +$67,071,360 $16.25 107
2020 Q2 39,307,332 $590,159,903 +$135,675,063 $15.02 90
2020 Q1 31,865,087 $231,287,000 +$63,846,487 $7.26 65
2019 Q4 23,097,585 $137,648,000 +$8,576,336 $5.96 54
2019 Q3 21,656,187 $91,586,000 +$26,415,199 $4.23 42
2019 Q2 15,375,371 $59,066,000 +$5,570,229 $3.84 41
2019 Q1 13,973,276 $57,854,000 +$9,460,253 $4.14 39
2018 Q4 11,728,077 $25,448,000 +$522,008 $2.17 36
2018 Q3 11,120,308 $42,813,000 +$2,424,453 $3.85 34
2018 Q2 10,631,974 $35,083,000 -$4,178,184 $3.30 35
2018 Q1 10,870,849 $48,282,000 +$3,972,904 $4.45 36
2017 Q4 10,576,715 $26,442,000 +$3,741,499 $2.50 37
2017 Q3 8,913,963 $33,869,000 -$2,319,225 $3.80 34
2017 Q2 8,943,614 $33,994,000 -$1,142,087 $3.80 36
2017 Q1 9,200,354 $39,559,000 +$3,929,235 $4.30 39
2016 Q4 8,937,685 $45,579,425 +$227,680 $5.10 49
2016 Q3 8,658,716 $54,510,000 +$9,580,174 $6.30 46
2016 Q2 7,123,813 $46,158,000 +$4,710,745 $6.48 41
2016 Q1 6,412,273 $35,778,820 +$1,301,148 $5.58 41
2015 Q4 6,163,378 $39,350,000 +$10,613,523 $6.39 49
2015 Q3 4,502,769 $23,270,760 -$1,241,474 $5.17 41
2015 Q2 4,469,489 $31,003,246 -$1,063,840 $6.94 43
2015 Q1 4,083,380 $32,603,303 +$1,085,507 $7.05 42
2014 Q4 3,439,266 $36,782,604 -$13,047,015 $8.33 39
2014 Q3 2,857,139 $52,681,832 +$30,108,934 $8.57 37
2014 Q2 2,631,385 $23,650,509 -$11,356,232 $8.99 34
2014 Q1 3,729,722 $39,199,863 +$6,976,688 $10.51 42
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .